Alopecia Areata Research Trial (52 Weeks)

Adults aged 18 to 65, inclusive, with a clinical diagnosis of moderate-to-severe alopecia areata (AA), defined as the presence of 50% or more and 95% or less total scalp hair loss, may qualify for a research trial. Qualified participants must have a current episode of hair loss lasting more than 3 months, but less than 7 years. The total duration since diagnosis of AA could be over 7 years.

Participants will receive investigational medication (active study drug) via injection. Study medication and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.

Total study duration will last about 52 weeks and involve about 14 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Alopecia
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Similar Studies

  • At this time there are no other studies for this condition. Please register to be contacted about upcoming studies for this condition.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more